HOME
ABOUT US
Company Profile
History
Member Enterprises
Corporate Culture
RESEARCH & PRODUCTS
R&D Innovation
Quality Control
Products Center
Wenning
Otty
Flowtide
Dr.Jun
NEWS
Company News
Health: The Reader’s Digest
CONTACT
中
EN
Health: The Reader's Digest
Fully embrace new media and expand sales channels
With the rapid development of the information era, the marketing pattern of traditional offline channels has undergone profound changes under the impact of new media. Against this backdrop of development, Peptide Pharmaceuticals has further strengthened its confidence in development, focusing on private domain traffic to build a "micro-ecological chain" system. The New Media Sales Department was officially established on September 1, 2020.
01
2020
/
09
Warmly celebrate the establishment of Jiangsu Putai Pharmaceutical Technology Co., Ltd.
On July 14, 2020, in order to better accelerate the pace of enterprise new drug research and development and meet the increasing market demand for personal health products, Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. (hereinafter referred to as Jiangsu Pulai) officially registered and established Jiangsu Pulai Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Jiangsu Pulai). After the establishment of Jiangsu Peptide, it will definitely improve the company's innovative products, management level, and marketing strategy in response to the current market demand for personal care and health products from customers, further integrate resources, improve the response speed to customer needs, and make greater contributions to the development of the group business belonging to Jiangsu Peptide.
14
07
The grand commencement ceremony for the construction of the new factory area was held
On September 22, 2017, the construction commencement ceremony for the company's new factory area located on Xingao Road in the High tech Zone of Jiangyin City was grandly held. Leaders from multiple departments of the Jiangyin Municipal Government and Chairman Chen Yuxin of the company attended the commencement ceremony. The new factory area will be constructed according to the standards of high starting point planning, high standard requirements, high-quality implementation, and efficient promotion. It is expected to enter production and use by 2019. The comprehensive operation of the new project will lay a solid foundation for the company's development. Under the strategic guidance of the chairman, the company will uphold the goal of high-quality development, continue to forge ahead, unite and collaborate, and strive to write new achievements that are realistic and innovative.
22
2017
Launch diversified product development strategy
To meet the diversified market demand for personal health care products from customers, the company has established a foothold in the current situation and, based on the Mosquitin Antibacterial Gel series of products, independently researched and innovated, and has successively developed Flowtide Antibacterial Lotion and Otty Antibacterial Lotion series products. After more than two years of operation and continuous improvement, the company's new production line is expected to achieve an annual production capacity of 1.2 million tubes of Mosquitoin, 300000 sets of Flowtide, and 300000 sets of Otty. At this point, the company has officially embarked on a development path of diversified sales of personal care products.
16
2015
08
Congratulations to our company on obtaining another national invention patent authorization
On April 2, 2014, the invention patent "Antipruritic composition and its application in the preparation of antipruritic agents" applied by our company was officially authorized by the China National Intellectual Property Administration after being accepted, examined and substantively examined. Invention patents symbolize a company's independent innovation ability and level, are the crystallization of professional knowledge and industry experience, and are also one of the company's core competitiveness. They help the company improve its soft power and market competitiveness, and provide strong technological support for its development.
02
2014
04